Dr Catherine Coombs discusses considerations for treatment selection in the context of a patient case with relapsed/refractory chronic lymphocytic leukemia.
EP. 1: Initial Impression and Prognosis of a Patient with R/R CLL
Catherine Coombs, MD, MS, introduces the case of a patient with relapsed/refractory CLL and shares her impressions on the patient’s initial presentation.
Watch
EP. 2: Considerations and Triggers for Initiation of Treatment in a Patient with R/R CLL
An expert in treating CLL discusses potential treatment options for a patient with relapsed/refractory CLL who has been previously treated with venetoclax plus obinutuzumab.
EP. 3: Patient Factors for Selecting Treatment in R/R CLL
Catherine Coombs, MD, MS, reviews factors that impact the selection of treatment in patients with CLL.
EP. 4: Existing Options for Second-Line Treatment of Patients with R/R CLL
A comprehensive review of existing second-line treatment options for patients with R/R CLL.
EP. 5: Considerations For Retreatment With Venetoclax in R/R CLL
Catherine Coombs, MD, MS, highlights available data and considerations for retreatment with venetoclax in the relapsed/refractory setting.
EP. 6: Emerging Treatment Options for Patients with R/R CLL
A detailed description of emerging treatment options for patients with relapsed/refractory CLL.
EP. 7: Novel Treatments and Combinations for the Treatment of Patients With CLL
Catherine Coombs, MD, MS, shares her thoughts on the future of treatment and where the field is moving for patients with CLL.